Stephen  Tatter  to  Receptor, EphA2
                            
                            
                                This is a "connection" page, showing publications  Stephen  Tatter  has written about  Receptor, EphA2.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.189
         
        
        
     
 
    
        
        - 
            Rossmeisl JH, Herpai D, Quigley M, Cecere TE, Robertson JL, D'Agostino RB, Hinckley J, Tatter SB, Dickinson PJ, Debinski W. Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas. Neuro Oncol. 2021 03 25; 23(3):422-434.
            
            
                Score: 0.189